Carfilzomib For Injection
Kyprolis 60 mgInjection
Kyprolis 60 mgInjection is prescribed for the treatment of multiple myeloma (a type of cancer of the bone marrow).
Kyprolis 60 mgInjection Composition :-
Kyprolis 60 mgInjection consists of : Carfilzomib 60 mg.
Carfilzomib is a proteasome inhibitor.
Kyprolis 60 mgInjection Uses :-
Kyprolis 60 mgInjection is an anti-cancer medicine. Kyprolis 60 mgInjection is a prescribed for the treatment of multiple myeloma (a type of cancer of the bone marrow).
Kyprolis 60 mgInjection is used single and in mixture with dexamethasone, daratumumab and dexamethasone, or lenalidomide and dexamethasone to treat people with multiple myeloma (a type of cancer of the bone marrow) who have been already treated with other medications.
Kyprolis 60 mgInjection Dosage :-
Kyprolis 60 mgInjection is a prescription medicine.
Take Kyprolis 60 mgInjection properly as your doctor tells you to take it.
Kyprolis 60 mgInjection comes as a powder to be mixed in liquid to be injected intravenously (into a vein). Kyprolis 60 mgInjection is given by a doctor or nurse in a medical office or clinic commonly over a period of 10 or 30 minutes.
Kyprolis 60 mgInjection can be given 2 days in a row each week for 3 weeks followed by a 12-day rest period or it can be given once a week for 3 weeks followed by a 13-days of rest period.
The duration of treatment will depend on how well your body react to the medication.
Kyprolis 60 mgInjection can cause serious or life-threatening reactions for up to 24 hours after you receive a dose of the medication. You will get certain medications to help cure a reaction before you get each dose of Kyprolis 60 mgInjection.
Kyprolis 60 mgInjection Side-effects :-
Common side effects of Kyprolis 60 mgInjection :
Low red blood cell count,
Diarrhea, tiredness (fatigue),
High blood pressure (hypertension),
Fever,
Upper respiratory tract infection,
Low platelets, cough,
Difficulty breathing,
Sleeplessness (insomnia).
These are not all the likely side effects of Kyprolis 60 mgInjection. Consult your doctor or pharmacist for more information. Make a call to your doctor for medical suggestion about side effects.
These are not all the possible side effects of Kyprolis 60 mgInjection. Consult your doctor and if you have any new or worsening side effects.
How Kyprolis 60 mgInjection Works :-
Kyprolis 60 mgInjection consists of : Carfilzomib.
Carfilzomib is a proteasome inhibitor.
Carfilzomib is a proteasome inhibitors. Carfilzomib works by ending or slowing the growth of cancer cells in your body.
Thus, Kyprolis 60 mgInjection treats multiple myeloma.
Precautions & Warnings :-
• Tell your doctor as soon as possible if you undergo any of these symptoms after your treatment: fever, chills, joint or muscle pain, flushing or swelling of the face, swelling of the throat, vomiting, weakness, shortness of breath, dizziness or fainting, or chest tightness or pain.
Be sure to inform your doctor how you are feeling during your treatment. Your doctor can stop your treatment for a while or reduce your dose of Kyprolis 60 mgInjection if you undergo side effects of the medication.
• Kyprolis 60 mgInjection can cause serious or life-threatening reactions for up to 24 hours after you receive a dose of the medication. You will get certain medications to help cure a reaction before you get each dose of Kyprolis 60 mgInjection.
• Kyprolis 60 mgInjection can cause critical side effects :
Heart problems
Kidney problems.
• You should contact your doctor as soon as possible if you undergo any of the following:
- Shortness of breath,
- Prolonged, unusual or excessive bleeding,
- Yellowing of the skin and/or eyes (jaundice),
- Headaches, seizures, confusion or loss of sight,
- Pregnancy (women must not take Kyprolis 60 mgInjection if they are pregnant or breastfeeding).
Any other side effect that trouble you or does not go away.
Kyprolis 60 mgInjection Mfg By :-
Dr Reddy's Laboratories Ltd
Kyprolis 60 mgInjection Price :-
MRP ₹ =
Kyprolis 60 mgInjection Storage :-
Kyprolis 60 mgInjection must be stored at room temperature.
Classification :-
Drug Name : Carfilzomib,
Therapeutics Indiaction : Treatment of multiple myeloma.